Grifols

We believe in empowering our people to become the leaders of tomorrow, and the GROW Program is a key part of that mission. 🚀 Over the course of 8 months, this global initiative provides high-potential employees with transformative experiences through group coaching, in-person and virtual development sessions, and invaluable mentor connections. We recently hosted our second in-person development sessions in Los Angeles and Barcelona . Key topics included self-leadership and building strong connections to overcome challenges. The LA session featured a Leadership panel, while the Barcelona session introduced an innovation workshop to tackle a real business learning challenge. At Grifols, developing our people is a cornerstone of our strategic vision. #LeadershipDevelopment #PeopleFirst #FutureLeaders #WeAreGrifols

We are proud to announce that the winner of the 2024 ALBUS Awards is Bryce A. Kerlin, MD, Professor of Pediatrics at The Ohio State University College of Medicine, and principal investigator at The Abigail Wexner Research Institute at Nationwide Children's Hospital. Dr. Kerlin is being recognized for his research project “Albumin-Dependent Endothelial Cytoprotection”, aiming to identify the specific molecular receptor responsible for albumin-dependent endothelial cytoprotection, with the goal of enabling the development of receptor agonists to stabilize the endothelium and improve cardiovascular outcomes in conditions associated with hypoalbuminemia. Founded in 2015 the ALBUS Program is an annual international award focused on innovative ideas related to albumin and its role as a therapeutic product. At Grifols, we are committed to pushing the boundaries of scientific knowledge to improve people’s health. Applications for the next Albus Award edition open on November 1st. For more information 👉 http://spr.ly/6045oDQev #hematology #GrifolsScientificAwards

On World Patient Safety Day, we join forces with patients, families, healthcare professionals and policy makers under the banner "Get it right, make it safe!" to emphasize the critical importance of accurate and timely diagnosis for patient safety. Grifols' legacy of innovation, from pioneering plasmapheresis to advancing diagnostic technologies, underscores our mission to ensure a safer tomorrow for patients worldwide. We believe that every patient deserves the highest standards of safety, quality, and reliability in their healthcare journey. #WorldPatientSafetyDay #PatientSafety #EarlyDiagnosis

At Grifols, safety is more than a regulatory requirement. It is a philosophy which goes hand in hand with quality. Since the 1970s, we have been at the forefront of advancing patient safety. Our Single Donor Human Plasma, an innovative solution designed for patients with coagulation disorders such as hemophilia, set a new standard in safety at Grifols. Freeze-dried plasma was obtained from a single donor and was used to treat one single patient. It helped protect against unidentified viruses. Today, decades later, our commitment to product safety remains unwavering. We continue to pioneer with the same dedication, ensuring that every product we offer is a step forward for patient care. #Biopharma #Since1909

We are proud to be named one of TIME Magazine’s ‘World’s Best Companies’ list for the second year in a row. Grifols climbs sharply to land in the top-third of the publication’s ranking of the 1,000 highest-performing companies, up 393 positions from last year. This steep ascent reflects the company’s relentless commitment to employee satisfaction, revenue growth and sustainability. Camille Alpi, Grifols Chief Human Resources & Talent Officer, highlights that this achievement is “a testament not only to the hard work and dedication of our employees but also to our long-term vision to lead with integrity and responsibility”. #WorldsBestCompanies #GrifolsTeam

We are pleased to announce that Dr. Tessa Schneeberger , from Philipps-University of Marburg/Schön Klinik Berchtesgadener Land (Germany) received the 2024 ALTA Award from Dr. Marion Trautmann, Grifols’ Global Medical Affairs in Pulmonogy, during the annual congress ERS Congress 2024 held in Vienna.  The also awarded Dr. Benoit Allard from Université de La Réunion (France), who could not attend the congress, will receive the award at a later date.     Founded in 2004 the ALTA Awards support annually independent research by young investigators to shape the future of AATD therapy.    The deadline for submitting nominations for the 2025 ALTA Award starts September 15ht, 2025.  More information here 👉 http://spr.ly/6043iOSST #pulmonology #geneticcopd #GrifolsScientificAwards

We believe that creating learning opportunities for the youth is key to ensuring a more diverse, equal and better future for society. We promote #STEM education programs across America and other countries with a special focus on girls, minorities and disadvantaged communities. In the last year: 🔬 17,000+ girls and boys benefited from our STEM educational programs, 🎓 $50,000+ in scholarships were made available for medical studies. The goal: Do more and do better to contribute to the health and quality of life of people around the world. #DiversityandInclusion #GrifolsSocialIniciatives

For the sixth consecutive year, our manufacturing site in Clayton, N.C. has been validated by Underwriters Laboratory UL Solutions as a “Zero Waste to Landfill” site. We are excited to maintain Gold-level validation for diverting from landfills 97% of the site’s waste, with 6% processing with Energy Recovery, by using recycling, composting, anaerobic digestion and other recovery techniques. ♻️ Effective waste management is part of our circular economy strategy, which includes seeking ways to reduce waste and pollution, as well as prolonging the useful life of materials. #environment #zerowastetolandfill #sustainability

As we continue to celebrate the 50th anniversary of our Clayton facility, today we bring you a story of family and commitment. This fifty-year success story would never have been possible without each and every person who has contributed with passion and determination, and who has brought the best of themselves to our facility. Our Clayton biopharma campus is one of the largest plasma fractionation plants in the world. Its 24/7/365 operation requires a dedicated, committed and exceptional team of employees, like the Medlin family. Their story started 35 years ago, when an 18-year-old Johnston Community College student entered the pooling area. #Biopharma #GrifolsClayton #WeAreHealthcare

Product safety for patients, donor safety and employee safety are our priorities. Our vertically integrated production process guarantees the highest standards of quality and safety, from donation to delivery of plasma-derived medicines to patients. We are very proud of our dedicated quality control team that oversees more than 390 plasma donation centers worldwide. Our rigorous standards are why healthcare professionals trust Grifols products and services. #GrifolsPlasma #GrifolsTeam